Myriad Genetics (MYGN) Other Non-Current Assets (2010 - 2026)

Myriad Genetics (MYGN) has reported Other Non-Current Assets for 15 consecutive years, with $5.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 27.27% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 27.27% YoY), while the FY2025 annual figure was $5.6 million, down 34.12% from the prior year.
• Other Non-Current Assets steadied at $5.6 million in Q1 2026 per MYGN's latest filing, from $5.6 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $22.1 million in Q2 2023 and bottomed at $5.6 million in Q4 2025.
• Historically, Other Non-Current Assets has averaged $11.7 million across 5 years, with a median of $8.8 million in 2022.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 151.14% — and 2025, when it plunged 60.0%.
• Myriad Genetics' Other Non-Current Assets stood at $15.5 million in 2022, then decreased by 0.65% to $15.4 million in 2023, then sank by 44.81% to $8.5 million in 2024, then slumped by 34.12% to $5.6 million in 2025, then changed by 0.0% to $5.6 million in 2026.
• Business Quant data shows MYGN's Other Non-Current Assets at $5.6 million in Q1 2026, $5.6 million in Q4 2025, and $6.6 million in Q3 2025.